Children

Children

191 bookmarks
Custom sorting
Morbidity and Mortality Weekly Report (MMWR) Section NavigationCOVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
Morbidity and Mortality Weekly Report (MMWR) Section NavigationCOVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
This report describes safety of the Pfizer-BioNTech COVID-19 vaccine for children aged 5–11 years. // 31.12.2021 Among 15 preliminary reports of myocarditis identified during the analytic period, 11 were verified (by provider interview or medical record review) and met the case definition for myocarditis¶¶¶; of these 11 children, seven recovered, and four were recovering at time of the report. VAERS received two reports of death during the analytic period; both are under review. These deaths occurred in two females, aged 5 and 6 years, both of whom had complicated medical histories and were in fragile health before vaccination. None of the data suggested a causal association between death and vaccination.
·cdc.gov·
Morbidity and Mortality Weekly Report (MMWR) Section NavigationCOVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
Children with pre-existing immunity to common cold demonstrate better protection against COVID-19
Children with pre-existing immunity to common cold demonstrate better protection against COVID-19
New data shows that, compared to adults, children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially activate pre-existing acquired immunity to prevalent common cold coronaviruses that cross-react with SARS-CoV-2 and protect them from severe disease. // 24.12.2021
·news-medical.net·
Children with pre-existing immunity to common cold demonstrate better protection against COVID-19
Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses
Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses
A new study shows that both antibody and cellular arms of the adaptive immune response against SARS-CoV-2 are displayed strong, sustained, and cross-reactive against other coronaviruses, in young children than the immune responses in adults. // 23.12.2021
·news-medical.net·
Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses
REACT-1 study shows COVID boosters and first doses in children are providing important protection
REACT-1 study shows COVID boosters and first doses in children are providing important protection
The Real-time Assessment of Community Transmission-1 (REACT-1) study has been tracking the transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) throughout England since May 2020. SARS-CoV-2 is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic. // 19.12.2021
·news-medical.net·
REACT-1 study shows COVID boosters and first doses in children are providing important protection
Alternative Covid-19 mitigation measures in school classrooms: analysis using an agent-based model of SARS-CoV-2 transmission
Alternative Covid-19 mitigation measures in school classrooms: analysis using an agent-based model of SARS-CoV-2 transmission
The SARS-CoV-2 epidemic continues to have major impacts on children’s education, with schools required to implement infection control measures that have led to long periods of absence and classroom closures. // 16.12.2021
·medrxiv.org·
Alternative Covid-19 mitigation measures in school classrooms: analysis using an agent-based model of SARS-CoV-2 transmission
COVID-19 trends and severity among symptomatic children aged 0 to 17 years in ten EU countries, 3 August 2020 to 3 October 2021
COVID-19 trends and severity among symptomatic children aged 0 to 17 years in ten EU countries, 3 August 2020 to 3 October 2021
To guide evidence-based prevention of COVID-19 in children, we estimated risks of severe outcomes in 820,404 symptomatic paediatric cases reported by 10 EU Member States between August 2020 and October 2021. // 29.11.2021
·medrxiv.org·
COVID-19 trends and severity among symptomatic children aged 0 to 17 years in ten EU countries, 3 August 2020 to 3 October 2021